Meet Acumetis at ISPOR EU 2026!
Connect with our GVA team
November 8 – 11, 2026 | Vienna, Austria
Acumetis will be attending ISPOR Europe 2026. Our Global Value & Access (GVA) team will be on-site to connect with industry leaders and discuss the evolving evidence, value, and access challenges facing life sciences organizations across global markets.
Building evidence strategies that support confident decision-making
Healthcare decision-makers are placing increasing demands on the quality, relevance, and applicability of evidence used to support pricing, reimbursement, and access decisions.
As HTA requirements evolve and expectations for real-world evidence continue to grow, organizations must ensure their evidence strategies are aligned with the needs of payers, clinicians, patients, and regulatory stakeholders.
This requires more than strong data. It requires a coordinated approach that connects evidence generation, health economics and outcomes research (HEOR), value communication, and market access planning to support confident decision-making throughout the product lifecycle.
Acumetis helps life sciences organizations develop evidence-led strategies that support successful value demonstration and market access. We work across the product lifecycle to align evidence generation, HEOR, HTA requirements, pricing strategy, and stakeholder engagement – helping teams build compelling value stories that that translate complex evidence into meaningful insights for decision-makers.
We partner with organizations to translate complex clinical and real-world evidence into clear, decision-relevant strategies that support reimbursement, access, and long-term value.
Key areas of focus
At ISPOR Europe 2026, our discussions will center on:
- Aligning evidence generation strategies with HTA, pricing, and reimbursement objectives
- Preparing for Joint Clinical Assessments (JCA) and evolving EU HTA requirements
- Developing robust PICO strategies to support evidence generation and HTA readiness
- Leveraging real-world evidence to strengthen value demonstration and address evidence gaps
- Developing compelling value narratives that resonate with payers and decision-makers
- Integrating HEOR, Medical Affairs, and Market Access perspectives into a unified evidence strategy
- Supporting global pricing and reimbursement strategies across diverse healthcare systems
- Navigating evolving policy, pricing, and reimbursement landscapes, including international reference pricing and MFN considerations
- Incorporating patient insights and outcomes into evidence and value frameworks
- Translating complex evidence into actionable insights that support market access success
Where to Find Us
You’ll find the Acumetis team at Booth #827 throughout the conference. Stop by to discuss your current priorities in evidence generation, value demonstration, HEOR, HTA, pricing, reimbursement, and patient access – or simply to learn more about how we support life sciences organizations in turning complex evidence into effective value and access strategies.
About Acumetis
Acumetis partners with life sciences organizations to navigate complex strategic, scientific, and commercial challenges across the product lifecycle.
We bring together medical, access, commercial, insights, and patient strategy into a coordinated path forward, building the knowledge and clarity that strengthen decision-making.
Our work spans Medical Affairs, Market Access, and Commercial Strategy, supporting teams in connecting evidence, engagement, and execution to drive meaningful outcomes.
At the core of our approach is a focus on reframing challenges, bringing strategic clarity, and creating critical connections that enable progress in practice.
Who You’ll Meet
Members of our Global Value & Access team will be attending ISPOR Europe 2026.
Additional attendee details will be announced closer to the conference.
Schedule a meeting with the Acumetis team to discuss your priorities and explore how we can support your evidence, value, and access strategy.